MODERN PHARMACEUTICAL TECHNOLOGIES FOR THE DEVELOPMENT OF PEDIATRIC DOSAGE FORMS
Vol. 6 No. 8 (2026): Eurasian Journal of Medical and Natural Sciences 75-83
Abstract
Pediatric patients represent a special population in pharmaceutical practice because physiological development, body weight, organ maturation, swallowing ability, taste preferences, and pharmacokinetic characteristics change considerably throughout childhood. Consequently, medicines developed primarily for adults cannot always be administered safely or conveniently to children. The development of appropriate pediatric dosage forms is therefore an important area of modern pharmaceutical technology. An effective pediatric formulation should provide accurate dosing, acceptable palatability, adequate chemical and physical stability, appropriate drug release, and ease of administration. This article reviews modern pharmaceutical technologies used in the development of pediatric dosage forms. Particular attention is given to oral liquid formulations, orally disintegrating tablets, mini-tablets, multiparticulate systems, modified-release formulations, orodispersible dosage forms, transdermal systems, and emerging technologies such as three-dimensional printing.
Keywords:
References
European Medicines Agency. Guideline on Pharmaceutical Development of Medicines for Paediatric Use. European Medicines Agency; 2013.
World Health Organization. Development of Paediatric Medicines: Points to Consider in Formulation. WHO Technical Report Series. Geneva: World Health Organization.
Krause J., Breitkreutz J. Improving drug delivery in paediatric medicine. Pharmaceutical Medicine. 2008;22:41–50.
Ivanovska V., Rademaker C.M.A., van Dijk L., Mantel-Teeuwisse A.K. Pediatric drug formulations: a review of challenges and progress. Paediatric Drugs. 2014;16:1–10.
Malkiel S., Harding R., Gaisford S. Mini-tablets: an emerging dosage form for pediatric drug delivery. Expert Opinion on Drug Delivery.
Klingmann V., Seiler L., Meissner T., Breitkreutz J. Acceptability of uncoated mini-tablets in young children. Journal of Pediatric Gastroenterology and Nutrition.
Preis M. Orally disintegrating films and mini-tablets: innovative dosage forms for pediatric patients. European Journal of Pharmaceutics and Biopharmaceutics.
Ranmal S., Cram A., Tuleu C. Age-appropriate and acceptable paediatric dosage forms: insights from children and caregivers. International Journal of Pharmaceutics.
Klingmann V., Seiler L., Meissner T., Breitkreutz J. Acceptability of multiple oral dosage forms in children. International Journal of Pharmaceutics.
European Medicines Agency. Reflection Paper: Formulations of Choice for the Paediatric Population. EMA.
International Council for Harmonisation. ICH Q8(R2): Pharmaceutical Development. ICH Harmonised Tripartite Guideline.
United States Food and Drug Administration. General Considerations for Pediatric Pharmacokinetic Studies for Drugs and Biological Products. FDA Guidance for Industry.
Samy R., et al. Three-dimensional printing technologies for pharmaceutical applications and personalized medicine. International Journal of Pharmaceutics.
Preis M., Breitkreutz J. Pediatric drug delivery: current strategies and future perspectives. Expert Opinion on Drug Delivery.
Tuleu C., et al. Formulation and acceptability of medicines for children: current challenges and emerging approaches. Advanced Drug Delivery Reviews.
Readership
Downloads
Published
Issue
Section
How to Cite
